Search Tag: type 2 diabetes

Cardiology Management

Glycaemic Therapy, β-Blockers Lower Mortality Risk in Diabetes

2016 14 Nov

A study published in the journal Diabetes Care demonstrates that intensive glycaemic therapy (IGT) has beneficial effects in type 2 diabetes (T2D) patients receiving treatment with β-blockers.   See Also: Prevalence of Global Diabetes Seriously Underestimated Intensive glycaemic control (IGC) decreases the risk for microvascular diseases such as diabetic... Read more

Cardiology Management

Pokémon Go May Decrease Type 2 Diabetes Burden

2016 26 Jul

According to leading diabetes researchers, the new smartphone craze Pokémon Go could prove to be an innovative solution to combat rising obesity levels and chronic disease. Pokémon Go is a virtual reality treasure hunt that requires players to walk to places within the real world and catch, train and batter monsters that appear on their mobile screens.... Read more

Cardiology Management

Adults Born with Heart Disease at Risk of Type 2 Diabetes

2016 19 Jul

According to a new study, children born with heart disease have a higher risk of developing Type 2 diabetes after the age of 30. The study is published in the Journal of the American Heart Association. Study findings show that the risk is even higher for those born with a cyanotic congenital heart disease (CHD) condition. The study was conducted with... Read more

IT Management

EHRs Detect Undiagnosed Type 2 Diabetes

2016 19 Feb

A group of UCLA researchers that mined thousands of electronic health records (EHRs) with the aim of finding a cheaper and more accurate way of identifying people with Type 2 diabetes discovered more than they expected. As well as developing a screening algorithm that could increase the number of correct Type 2 diabetes diagnoses of the disease by... Read more

Cardiology Management

New Tools Determine Risk of CHD in Diabetics

2016 02 Feb

According to a recent report, new tools could be used for improving the treatment of heart disease in patients with type 2 diabetes. This could prove to be quite significant since nearly two-thirds of deaths among people with type 2 diabetes is related to cardiovascular disease. The report is published in the Journal of the American College of Cardiology:... Read more

Executive Health Management

Obesity Surgery - Who Should Get Priority?

2015 25 Sep

According to new research published in The Lancet Diabetes & Endocrinology, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes. Most healthcare systems typically prioritise obesity surgery on the basis of a person's BMI. Those with the highest... Read more

Executive Health Management

Pharmacists Play Critical Role in Improving Patient Health

2015 18 Jun

According to a study conducted by Scot H. Simpson, professor in the faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, pharmacists on primary care teams can have a significant impact on the treatment of blood pressure in patients with Type 2 diabetes. The study titled “Pharmacists on primary care teams: Effect on antihypertensive medication... Read more

Cardiology Management

Preventing CVD in Type 2 Diabetes Patients

2015 10 Feb

Researchers have found that blood pressure (BP)-lowering treatment among patients with type 2 diabetes mellitus is associated with a lower risk of cardiovascular disease (CVD) and heart disease events and improved mortality. They noted that each 10-mm Hg lower systolic BP was associated with a lower risk of mortality, CVD events, coronary heart disease... Read more

Pharmacy Management

Once-Daily Injection Approved for Type 2 Diabetes and Moderate CKD

2015 24 Jan

A once-daily injection has been approved in the UK for adults with type 2 diabetes and moderate renal impairment. Approximately one million people in the UK have type 2 diabetes and around 40 percent of them are affected by moderate chronic kidney disease. Renal impairment is one of the most common long-term complications associated with diabetes... Read more

Pharmacy Management

Sanofi And MannKind To Launch Inhalable Insulin

2014 14 Nov

MannKind and Sanofi are set to launch their inhalable insulin product. Approved earlier this year by the FDA, Afrezza is a fast-acting insulin to be taken at mealtimes. The drug is effective for both Type 1 and Type 2 diabetes. Seven years ago, Pfizer launched Exubera, another inhalable insulin. When Exubera was introduced, it was believed to be a... Read more


Endorsed Companies